Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacek Rysz

Showing results (61-70 of 330) with videos related to

Pageof 33
Sort By:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 1, 2009
Time for new indications for statins?Maciej Banach, Dimitri P Mikhailidis, Sverre E Kjeldsen, et al.
Thyroid Research|April 4, 2009
The mechanisms of atrial fibrillation in hyperthyroidismAgata Bielecka-Dabrowa, Dimitri P Mikhailidis, Jacek Rysz, et al.
International Journal of Molecular Sciences|May 13, 2023
Why Does Rehabilitation Not (Always) Work in Osteoarthritis? Does Rehabilitation Need Molecular Biology?Adam Zdziechowski, Anna Gluba-Sagr, Jacek Rysz, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 2, 2010
Influence of pharmacological treatment on blood flow and muscle perfusion in patients with obliterative atheromatosis assessed with isotopic methods. A pilot studyWieslaw Tryniszewski, Dariusz Nowak, Marian Brocki, et al.
International Urology and Nephrology|October 24, 2015
Assessment of the relationship between selected cardiovascular risk factors and the indices of intima-media thickness and coronary artery calcium score in various stages of chronic kidney diseaseAnna Szarejko-Paradowska, Anna Gluba-Brzózka, Robert Pietruszyński, et al.
Nutrients|May 16, 2017
The Effect of Diet on the Survival of Patients with Chronic Kidney DiseaseJacek Rysz, Beata Franczyk, Aleksandra Ciałkowska-Rysz, et al.
Expert Opinion on Pharmacotherapy|July 21, 2011
What is the risk of hyperkalaemia in heart failure?Agata Bielecka-Dabrowa, Jacek Rysz, Dimitri P Mikhailidis, et al.
International Journal of Molecular Sciences|January 23, 2020
The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular DiseaseJacek Rysz, Anna Gluba-Brzózka, Magdalena Rysz-Górzyńska, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|July 7, 2005
[Determination of selected biomarkers can be used in monitoring oxidative stress in the course of chronic failure]Elbieta Potargowicz, Jacek Rysz, Ewa Szerszenowicz, et al.
Lipids in Health and Disease|November 1, 2017
The role and function of HDL in patients with diabetes mellitus and the related cardiovascular riskMarek Femlak, Anna Gluba-Brzózka, Aleksandra Ciałkowska-Rysz, et al.
Pageof 33

Showing results (61-70 of 330) with videos related to

Sort By:
Pageof 33
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 1, 2009
Time for new indications for statins?Maciej Banach, Dimitri P Mikhailidis, Sverre E Kjeldsen, et al.
Thyroid Research|April 4, 2009
The mechanisms of atrial fibrillation in hyperthyroidismAgata Bielecka-Dabrowa, Dimitri P Mikhailidis, Jacek Rysz, et al.
International Journal of Molecular Sciences|May 13, 2023
Why Does Rehabilitation Not (Always) Work in Osteoarthritis? Does Rehabilitation Need Molecular Biology?Adam Zdziechowski, Anna Gluba-Sagr, Jacek Rysz, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|December 2, 2010
Influence of pharmacological treatment on blood flow and muscle perfusion in patients with obliterative atheromatosis assessed with isotopic methods. A pilot studyWieslaw Tryniszewski, Dariusz Nowak, Marian Brocki, et al.
International Urology and Nephrology|October 24, 2015
Assessment of the relationship between selected cardiovascular risk factors and the indices of intima-media thickness and coronary artery calcium score in various stages of chronic kidney diseaseAnna Szarejko-Paradowska, Anna Gluba-Brzózka, Robert Pietruszyński, et al.
Nutrients|May 16, 2017
The Effect of Diet on the Survival of Patients with Chronic Kidney DiseaseJacek Rysz, Beata Franczyk, Aleksandra Ciałkowska-Rysz, et al.
Expert Opinion on Pharmacotherapy|July 21, 2011
What is the risk of hyperkalaemia in heart failure?Agata Bielecka-Dabrowa, Jacek Rysz, Dimitri P Mikhailidis, et al.
International Journal of Molecular Sciences|January 23, 2020
The Role and Function of HDL in Patients with Chronic Kidney Disease and the Risk of Cardiovascular DiseaseJacek Rysz, Anna Gluba-Brzózka, Magdalena Rysz-Górzyńska, et al.
Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego|July 7, 2005
[Determination of selected biomarkers can be used in monitoring oxidative stress in the course of chronic failure]Elbieta Potargowicz, Jacek Rysz, Ewa Szerszenowicz, et al.
Lipids in Health and Disease|November 1, 2017
The role and function of HDL in patients with diabetes mellitus and the related cardiovascular riskMarek Femlak, Anna Gluba-Brzózka, Aleksandra Ciałkowska-Rysz, et al.
Pageof 33